Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry — Eduard Vieta (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry
Shared by
Eduard Vieta
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry
Article
2025
en
Authors
Eduard Vieta
VO
Vincenzo Oliva
Related publications
Article
2025
<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
Tommaso Bucci
,
Uazman Alam
,
Grégoire Fauchier
,
Lisa Lochon
,
Arnaud Bisson
,
Pierre Henri Ducluzeau
,
Professor Gregory Lip
,
Laurent Fauchier
Article
2025
GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Anastasios Tentolouris
,
Ioannis Ntanasis‐Stathopoulos
,
Charalampos Filippatos
,
Evangelos Terpos
,
Efstathios Kastritis
,
Ernesto Ruiz Duque
,
Meletios A Dimopoulos
,
Maria Gavriatopoulou
,
Αlexandros Briasoulis
Letter
2025
GLP-1 receptor agonists: even for kidney transplant recipients with pre-existing diabetes?
Monica Cortinovis
,
Norberto Perico
,
Giuseppe Remuzzi
Article
2024
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
Yi‐Hsin Chan
,
Tze‐Fan Chao
,
Shao-Wei Chen
,
Hsin‐Fu Lee
,
Pei‐Ru Li
,
Yung‐Hsin Yeh
,
Chi‐Tai Kuo
,
Lai‐Chu See
,
Professor Gregory Lip
Article
2025
Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study
Ioannis Ntanasis‐Stathopoulos
,
Anastasios Tentolouris
,
Charalampos Filippatos
,
Αlexandros Briasoulis
,
Meletios A Dimopoulos
,
Maria Gavriatopoulou
Discussion(0)
No comments yet. Be the first to comment.